Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines

BACKGROUND: There are conflicting data as to whether co-treatment with 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) under azathioprine (AZA) or 6-mercaptopurine (6-MP) therapy may influence 6-thioguanine nucleotide (6-TGN) concentrations, and whether this combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Looser, Rahel, Doulberis, Michael, Rossel, Jean-Benoit, Franc, Yannick, Müller, Daniel, Biedermann, Luc, Rogler, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662061/
https://www.ncbi.nlm.nih.gov/pubmed/38023976
http://dx.doi.org/10.20524/aog.2023.0832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662061/
https://www.ncbi.nlm.nih.gov/pubmed/38023976
http://dx.doi.org/10.20524/aog.2023.0832

Ejemplares similares